CHA University: Clinical Trials

67 trials sponsored by CHA University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 20 unknown, 12 recruiting, 4 not yet recruiting. 22 Not applicable, 10 Phase 3, 7 Phase 4, 6 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable22Completed 11, Unknown 7, Recruiting 3, Not yet recruiting 1
Phase 310Completed 9, Terminated 1
Phase 47Unknown 3, Completed 2, Not yet recruiting 1, Recruiting 1
Phase 16Completed 2, Recruiting 2, Unknown 2
Phase 26Completed 2, Unknown 2, Not yet recruiting 1, Recruiting 1

Follow CHA University: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial to Evaluate the Efficacy and Safety of Meltz, a Digital Therapeutic Device, for Improving Panic Symptoms in Patients With Panic Disorder
Meltz, Sham Application - Panic Disorder, Agoraphobia
Not applicableNot yet recruitingAIMNEXT1202026-10-012026-10-23
Bile ctDNA Genomic Profiling and Concordance With Tumor Tissue in Biliary Tract Cancer
Bile Sampling for ctDNA Analysis - Biliary Tract Cancer (BTC)
Not yet recruitingCHA University1002026-10-012026-10-13
Atezolizumab, Bevacizumab, and Tocilizumab in Advanced Hepatocellular Carcinoma
Atezolizumab, Bevacizumab, Tocilizumab - Hepatocellular Carcinoma (HCC)
Phase 2Not yet recruitingCHA University512026-09-012026-08-19
Fostrox Plus Lenvatinib vs Lenvatinib in Advanced Hepatocellular Carcinoma After First-line Immunotherapy
Fostrox, Lenvatinib - Hepatocellular Carcinoma (HCC)
Phase 2RecruitingCHA University802026-05-142026-05-22
Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Healthy Adults
Walking Without Bot-Fit, Bot-Fit Aqua Mode, Bot-Fit Boost Mode - Postprandial Glycemic Response, Healthy Adults
Not applicableCompletedCHA University222026-03-172026-07-10
Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Patients With Type 2 Diabetes
Bot-Fit Aqua Mode, Bot-Fit Boost Mode, Non-Assisted Walking - Type 2 Diabetes Mellitus (T2DM)
Not applicableCompletedCHA University142026-03-022026-07-09
A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma
MSC11FCD - Glioblastoma (GBM), Newly Diagnosed Glioblastoma Multiforme
Phase 1RecruitingCHA University102025-10-232026-01-22
ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer
Blood Sampling for ctDNA Analysis - Biliary Tract Cancer
RecruitingCHA University1002025-09-012026-03-18
Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC
Circulating Tumor DNA (ctDNA) Testing (ctDNA-based Next-Generation Sequencing (NGS)) - Biliary Tract Cancer
RecruitingCHA University2002025-09-012026-03-18
The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial
AI-ECG - Myocardial Infarction (MI), Chest Pain Rule Out Myocardial Infarction
Not applicableRecruitingCHA University46702025-07-012026-07-28
Medipixel XA-Assisted PCI in Coronary Artery Disease
Medipixel XA-Assisted Percutaneous Coronary Intervention - Percutaneous Coronary Intervention (PCI), Coronary Arterial Disease (CAD)
Not applicableRecruitingCHA University8302025-05-152026-10-21
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
AST-201 - Neoplasms, Carcinoma, Hepatocellular
Phase 1RecruitingAptamer Sciences, Inc.702025-03-112026-03-27
Carbohydrate Mouth Rinsing and Cognitive Response During Exercise
Carbohydrate Mouth Rinse, Placebo Mouth Rinse, Music Listening - Exercise Performance of Fit Athletes
Not applicableCompletedCHA University112025-02-282025-08-01
Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)
Mild Cognitive Impairment, Dementia
RecruitingEwha Womans University Mokdong Hospital40002025-02-242025-03-21
The Analysis of Efficacy Factors for Autologous Platelet-Rich Plasma Therapy in the Treatment of Elbow Tendinopathy
Autologous Platelet-Rich Plasma (PRP) Injection - Elbow Tendinopathy
Phase 4Not yet recruitingCHA University302025-02-012025-02-07
Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer
Gemcitabine, Cisplatin, Nab-paclitaxel, and Tislelizumab. - Locally Advanced Biliary Tract Cancers, Metastatic Biliary Tract Cancers
RecruitingCHA University612024-10-012025-09-15
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
lenvatinib plus pembrolizumab - Biliary Tract Cancer, Cholangiocarcinoma
RecruitingCHA University1002024-09-232026-03-18
MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study
Colchicine 0.6 mg - Acute Coronary Syndrome
Phase 4RecruitingCHA University4902024-08-052026-02-18
RCVR (Residual CardioVascular Risk) Prospective Study
Blood Sample, DICOM Dataset - Coronary Artery Disease
Active not recruitingCHA University5002024-06-172026-02-18
Development of the Neuroimaging Biomarker-based Prediction Model of Anxiety-related Disorders: Effect of Mindfulness-based Cognitive Therapy Using Neuroscience on the Brain
Mindfulness-based cognitive therapy using neuroscience (NMBCT) - Anxiety Depression
Not applicableUnknownCHA University642023-09-012023-08-25

Showing 20 of 67. Sign in to see all of them.

Conditions studied

Carcinoma, Hepatocellular (7)  ·  Biliary Tract Neoplasms (6)  ·  Glaucoma (4)  ·  Acute Coronary Syndrome (2)  ·  Cerebral Palsy (2)  ·  Chest Pain (2)  ·  Cholangiocarcinoma (2)  ·  Glioblastoma (2)  ·  Liver Neoplasms (2)  ·  Myocardial Infarction (2)  ·  Myofibroma (2)  ·  Neoplasms (2)  ·  Ovarian Cysts (2)  ·  Agoraphobia (1)  ·  Alzheimer Disease (1)

Interventions

Liquid Biopsy (5)  ·  Bevacizumab (4)  ·  atezolizumab (4)  ·  130-nm albumin-bound paclitaxel (2)  ·  Base Sequence (2)  ·  Blood Specimen Collection (2)  ·  Brimonidine Tartrate (2)  ·  Vasopressins (2)  ·  lenvatinib (2)  ·  pembrolizumab (2)  ·  Amisulpride (1)  ·  Circulating Tumor DNA (1)  ·  Cisplatin (1)  ·  Colchicine (1)  ·  Conversion to Open Surgery (1)

Countries

South Korea (62)  ·  India (1)  ·  Italy (1)  ·  Romania (1)  ·  Vietnam (1)

Top investigators

Hong Jae Chon, MD. PhD (3)  ·  Hongjae Chon, MD,PhD (3)  ·  MinYoung Kim, M.D., Ph.D. (3)  ·  Seungsoo Rho, MD, PhD (3)  ·  Taejong Song, MD (3)  ·  Kyunghoon Min, MD, PhD (2)  ·  Seung-Bo Park, Ph.D (2)  ·  Seung-Yul Lee, MD (2)  ·  Taejong Song, MD PhD (2)  ·  Cheolhyeon Cho (1)  ·  DH Jung, MPH.M.D. (1)  ·  David Lee (1)  ·  Ee-kyung Kim (1)  ·  Geon-ha Kim (1)

Results publications

PMID 16527888, PMID 20332205, PMID 20375404, PMID 20516446, PMID 21321535, PMID 23108136, PMID 24630293, PMID 24856464, PMID 24903197, PMID 25601652, PMID 26075931, PMID 26263079, PMID 26701971, PMID 26822708, PMID 26860800, PMID 27932229, PMID 28434648, PMID 29141662, PMID 29875066, PMID 29972759, PMID 31032109, PMID 32402160, PMID 32832493, PMID 33246489, PMID 33798493, PMID 35861828, PMID 35967452, PMID 36115677, PMID 36116775, PMID 36734415, PMID 37075781, PMID 38012820, PMID 38148064, PMID 38319896, PMID 38330380, PMID 38650446, PMID 39614852, PMID 39912435, PMID 41167798, PMID 41221450, PMID 41657474, PMID 42118778, PMID 42312765